Health Condition 1: F400- Agoraphobia Health Condition 2: F401- Social phobias Health Condition 3: F402- Specific (isolated) phobias Health Condition 4: F410- Panic disorder [episodic paroxysmal anxiety] Health Condition 5: F411- Generalized anxiety disorder
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: For Anxiety Disorder Group: Current DSM-5 diagnosis of anxiety disorders (GAD, SAD, PD with or without Agoraphobia, or Phobic Anxiety Disorders); Minimum 7th standard education; Fluent in English, Hindi, Malayalam, or Kannada; Right-handed as per the Edinburgh Handedness Inventory; Normal or corrected vision and/or hearing For Non Clinical Controls:Minimum 7th standard education;Fluent in English, Hindi, Malayalam, or Kannada;Right-handed as per the Edinburgh Handedness Inventory; Normal or corrected vision and/or hearing
Exclusion criteria
Exclusion criteria: For Anxiety Disorder Group: Presence of comorbid Somatoform or Dissociative Disorder, OCD, and/or Adjustment or Acute stress reaction, Severe Depression, Bipolar Disorder, or Schizophrenia; Presence of neurological conditions such as epilepsy, cerebrovascular disease, and other neurodegenerative disorders, as per clinical interview and file diagnosis; Evidence of intellectual disability; History of drug and alcohol dependence, excluding Nicotine; Sensorimotor impairments that can interfere with test performance For Non Clinical Controls: Presence of any current psychiatric diagnosis evaluated using the DIAMOND screener; Presence of neurological conditions such as Epilepsy, cerebrovascular disease, and other neurodegenerative disorders, as per clinical interview; Evidence of intellectual disability Sensorimotor impairments that interfere with assessments/test performance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive Flexibility Index (Uncertainty) and Cognitive Flexibility Index (Conflict)Timepoint: The study will be cross-sectional. Hence it will be measured only once at baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety SeverityTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Depression SeverityTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Intolerance of UncertaintyTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Anxiety SensitivityTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;ImpulsivityTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;PerfectionismTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Metacognitive RegulationTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Duration of Illness (DOI)Timepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;ComorbiditiesTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline.;Treatment HistoryTimepoint: The study will be cross-sectional. Hence it will be measured only once at baseline. | — |
Countries
India
Contacts
National Institute of Mental Health and Neuro Sciences (NIMHANS)